Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06435897 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial
NCT06435897 · ClinicalTrials.gov record · last posted 2026-08-27

Autoimmune Disease Treatment With Mesenchymal Stem Cells (MSCs) and CAR-T Cells

StatusNot Yet Recruiting
PhasePhase 1/2
Started2027-06-30
View on ClinicalTrials.gov ↗
from the ClinicalTrials.gov record
The purpose of this study is to assess the feasibility, safety and efficacy of mesenchymal stem cells (MSCs) in combination with CAR-T cells in treating autoimmune disease. Another goal of the study is to learn more about the safety and function of the MSCs combined with CAR-T cells and their long term effects in autoimmune disease patients.

Protocol amendment history 3 changes detected by DataLookout

2026-08-28
Trial status changed: Recruiting → Not Yet Recruiting
2026-08-28
Primary completion pushed: 2027-07-15 → 2028-12-31
2026-08-28
Completion pushed: 2027-12-31 → 2029-12-31
Trial Details
NCT Number NCT06435897
Lead Sponsor Shenzhen Geno-Immune Medical Institute
Conditions Autoimmune Diseases
Enrollment 30 participants
Start Date 2027-06-30
Primary Completion 2028-12-31 (estimated)
Study Completion 2029-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-08-27